1
|
Ismaeel A, Lavado R, Koutakis P. Metabolomics of peripheral artery disease. Adv Clin Chem 2022; 106:67-89. [PMID: 35152975 DOI: 10.1016/bs.acc.2021.09.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
The science of metabolomics has emerged as a novel tool for studying changes in metabolism that accompany different disease states. Several studies have applied this evolving field to the study of various cardiovascular disease states, which has led to improved understanding of metabolic changes that underlie heart failure and ischemic heart disease. A significant amount of progress has also been made in the identification of novel biomarkers of cardiovascular disease. Another common atherosclerotic disease, peripheral artery disease (PAD) affects arteries of the lower extremities. Although certain aspects of the disease pathophysiology overlap with other cardiovascular diseases in general, PAD patients suffer unique manifestations that lead to significant morbidity and mortality as well as severe functional limitations. Furthermore, because over half of PAD patients are asymptomatic, there is a need for improved diagnostic and screening methods. Identification of metabolites associated with the disease may thus be a promising approach for PAD. However, PAD remains highly understudied. In this chapter, we discuss the application of metabolomics to the study of PAD.
Collapse
Affiliation(s)
- Ahmed Ismaeel
- Department of Biology, Baylor University, Waco, TX, United States
| | - Ramon Lavado
- Department of Environmental Science, Baylor University, Waco, TX, United States
| | | |
Collapse
|
2
|
Semporé WY, Chao De La Barca JM, Hersant J, Ouédraogo N, Yaméogo TM, Henni S, Reynier P, Abraham P. Exercise-Induced Plasma Metabolomic Profiles in Patients With Peripheral Arterial Disease. Front Physiol 2021; 12:758085. [PMID: 34867463 PMCID: PMC8637284 DOI: 10.3389/fphys.2021.758085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2021] [Accepted: 10/19/2021] [Indexed: 11/26/2022] Open
Abstract
Aim: A better knowledge of the biological consequences in the blood of these exercise-induced ischemic events in lower extremity artery disease (LEAD) may improve the prospects of disease management. We explored the preminus postexercise metabolomic difference in 39 patients with LEAD referred for a treadmill oximetry test [transcutaneous oximetry (TcPO2)]. Methods: Ischemia was estimated through the sum of decrease from rest of oxygen pressure (DROPs) (limb TcPO2 changes minus chest TcPO2 changes) at buttocks, thighs, and calves regions. Targeted metabolomic analyses measuring 188 metabolites were performed on a few microliters blood samples taken at the earlobe at rest and 3 min after exercise. Results: Maximum walking distance (MWD) was 290 m (120–652 m) and ankle brachial index (ABI) was 0.67 ± 0.17. Supervised paired partial least squares discriminant analysis based on 23,345 models showed good predictive performance for test sets with a median area under the receiver operating characteristic (AUROC) curve value of 0.99 and a p-value of 0.00049. The best discriminant metabolites contributing to the model included a subset of 71 (47%) of the 150 accurately measured metabolites in the plasma, comprising 3 acylcarnitines, 3 amino acids, 5 biogenic amines, 9 sphingomyelin, 7 lysophosphatidylcholines, and 44 phosphatidylcholines. In addition, 16 of these metabolites were found to correlate with one or more severity scores of the LEAD. Conclusion: Our results provide new insights into the biological changes that accompany exercise in LEAD and contribute to a better understanding of walking impairment pathophysiology in LEAD, highlighting new candidate biomarkers.
Collapse
Affiliation(s)
- Wendsèndaté Yves Semporé
- Centre MURAZ, National Institute of Public Health, Bobo Dioulasso, Burkina Faso.,Sports Medicine Department, University Hospital of Angers, Angers, France.,MitoVasc Research Unit, CNRS 6015, INSERM U-1083, University of Angers, Angers, France
| | - Juan Manuel Chao De La Barca
- MitoVasc Research Unit, CNRS 6015, INSERM U-1083, University of Angers, Angers, France.,Biochemistry and Molecular Biology Laboratory, University Hospital of Angers, Angers, France
| | - Jeanne Hersant
- Vascular Medicine Department, University Hospital of Angers, Angers, France
| | - Nafi Ouédraogo
- Physiology, Nazi Boni University, Bobo Dioulasso, Burkina Faso
| | | | - Samir Henni
- MitoVasc Research Unit, CNRS 6015, INSERM U-1083, University of Angers, Angers, France.,Vascular Medicine Department, University Hospital of Angers, Angers, France
| | - Pascal Reynier
- MitoVasc Research Unit, CNRS 6015, INSERM U-1083, University of Angers, Angers, France.,Biochemistry and Molecular Biology Laboratory, University Hospital of Angers, Angers, France
| | - Pierre Abraham
- Sports Medicine Department, University Hospital of Angers, Angers, France.,MitoVasc Research Unit, CNRS 6015, INSERM U-1083, University of Angers, Angers, France.,Vascular Medicine Department, University Hospital of Angers, Angers, France
| |
Collapse
|
3
|
Wang L, Goldberg EM, Taylor CG, Zahradka P, Aliani M. Analyses of serum and urinary metabolites in individuals with peripheral artery disease (PAD) consuming a bean-rich diet: Relationships with drug metabolites. Appl Physiol Nutr Metab 2021; 47:243-252. [PMID: 34699735 DOI: 10.1139/apnm-2021-0495] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Peripheral artery disease (PAD) has high morbidity and mortality rates. A metabolomics approach was employed to determine whether consumption of bean-rich diets for 8 weeks would impact the metabolomic profile of PAD individuals. Serum and urine, collected from 54 participants with clinical PAD at baseline and after 8 weeks on 0.3 cups beans/d (n=19), 0.6 cups beans/d (n= 20), or control (n=23) diet, and the beans were extracted and analyzed using LC-QTOF-MS. As a result, PGE2 p-acetamidophenyl ester, PGF2α diethyl amide and 5-L-glutamyl-L-alanine were significantly changed in the serum or urine of bean groups compared to control. Significant changes (P<0.05) in the profile and/or levels of 22 flavonoids present in bean extracts showed the potential importance of the mixture of beans used in this study. In a subset of participants taking metoprolol, after 8 weeks the bean-rich diets significantly elevated metoprolol in the serum while reducing it in urine compared to baseline. In addition, the diets significantly enhanced the urinary excretion of metformin. In conclusion, several biochemical pathways including prostaglandins and glutathione were affected by bean consumption. Significant changes in the metabolism of metoprolol and metformin with bean consumption suggested the presence of diet-drug interactions that may require adjustment of the prescribed dose. ClinicalTrials.gov Identifier: NCT01382056 Novelty: • Bean consumption by people with PAD alters the levels of certain metabolites in serum and urine • Different bean types (black, red kidney, pinto, navy) have unique flavonoid profiles • Metabolomics revealed potential diet-dug interactions as serum and/or urinary levels of metoprolol and metformin are modified by bean consumption.
Collapse
Affiliation(s)
- Le Wang
- University of Manitoba, 8664, Winnipeg, Manitoba, Canada;
| | | | - Carla G Taylor
- St. Boniface Hospital Research Centre, Canadian Centre for Agri-Food Research in Health and Medicine, Winnipeg, Manitoba, Canada.,University of Manitoba, Physiology, Winnipeg, Manitoba, Canada;
| | - Peter Zahradka
- St. Boniface Hospital Research Centre, Canadian Centre for Agri-Food Research in Health and Medicine, Winnipeg, Manitoba, Canada.,University of Manitoba, Physiology, Winnipeg, Manitoba, Canada;
| | - Michel Aliani
- University of Manitoba, 8664, Winnipeg, Manitoba, Canada, R3T 2N2;
| |
Collapse
|
4
|
Zheng J, Guo Y, Hu B, Zhu L, Yang Y, Li S, Li N, Liu H. Serum metabolomic profiles reveal the impact of BuZangTongLuo formula on metabolic pathways in diabetic mice with hindlimb ischemia. JOURNAL OF ETHNOPHARMACOLOGY 2020; 258:112928. [PMID: 32371144 DOI: 10.1016/j.jep.2020.112928] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/17/2020] [Revised: 03/18/2020] [Accepted: 04/26/2020] [Indexed: 06/11/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE BuZangTongLuo Formula (BZTLF) was the decoction of eight traditional Chinese medicines including Astragalus membranaceus, Dioscorea opposita, Salvia miltiorrhiza, Scrophularia ningpoensis, Ophiopogon japonicus, Panax ginseng, Fritillariae cirrhosae and Whitmania pigra. This formula has been used as an effective remedy for treatment of diabetic ischemia clinically. AIM OF THE STUDY In previous study, we have reported the therapeutic effect of BZTLF on diabetic vascular dysfunction. However, it remains obscure about the role of metabolic pathways in BZTLF-initiated improvement on hindlimb ischemia. MATERIALS AND METHODS Diabetic mice with hindlimb ischemia were orally administrated with BZTLF by gavage. The serum samples were prepared for untargeted metabolomic analysis by ultra-performance liquid chromatography-mass spectrometer. The metabolic network was built by integrating metabolite data with the Gene Expression Omnibus (GEO) dataset (GSE3313). Further, quantitative PCR was used to confirm the key target genes. RESULTS BZTLF treatment remarkably led to the reversal of changed metabolite levels in serum of diabetic mice with hindlimb ischemia, which mainly derived from bacteria, plant and signaling molecules. Also, BZTLF reshaped the metabolic pathways, especially those responsible for metabolism of lipid, gluthanine and tryptophan. In addition, BZTLF led to the reduction of lysophosphatidic acids (LPAs) and increment of triglycerides (TGs) conjugation with non-saturated fatty acids in serum. BZTLF significantly restored the down-regulation of vascular endothelial growth factor receptor 2 (VEGFR2) and endothelial nitric oxide synthase (eNOS) or the up-regulation of interleukin 4-induced 1 (IL4I1) and cytochrome P450 family 1 subfamily B member 1 (CYP1B1) at mRNA level, which were key regulatory genes located in metabolic pathways of glutamate and tryptophan. CONCLUSIONS BZTLF improved hindlimb ischemia in diabetic mice by the positive regulation of metabolome changes in serum.
Collapse
Affiliation(s)
- Junping Zheng
- Chongqing Academy of Chinese Materia Medica, Nanshan Road 34, Chongqing, 400065, China; College of Life Sciences, Wuchang University of Technology, Jiangxia Avenue 16, Wuhan, 430223, China; College of Basic Medicine, Hubei University of Chinese Medicine, Huangjiahu 16, Wuhan, 430065, China
| | - Yanlei Guo
- Chongqing Academy of Chinese Materia Medica, Nanshan Road 34, Chongqing, 400065, China
| | - Baifei Hu
- Chongqing Academy of Chinese Materia Medica, Nanshan Road 34, Chongqing, 400065, China; College of Basic Medicine, Hubei University of Chinese Medicine, Huangjiahu 16, Wuhan, 430065, China
| | - Lin Zhu
- Chongqing Academy of Chinese Materia Medica, Nanshan Road 34, Chongqing, 400065, China; College of Basic Medicine, Hubei University of Chinese Medicine, Huangjiahu 16, Wuhan, 430065, China
| | - Yong Yang
- Chongqing Academy of Chinese Materia Medica, Nanshan Road 34, Chongqing, 400065, China
| | - Shengrong Li
- Chongqing Academy of Chinese Materia Medica, Nanshan Road 34, Chongqing, 400065, China
| | - Na Li
- Chongqing Academy of Chinese Materia Medica, Nanshan Road 34, Chongqing, 400065, China
| | - Hongtao Liu
- Chongqing Academy of Chinese Materia Medica, Nanshan Road 34, Chongqing, 400065, China; College of Basic Medicine, Hubei University of Chinese Medicine, Huangjiahu 16, Wuhan, 430065, China.
| |
Collapse
|
5
|
Serum Metabolic Signatures of Chronic Limb-Threatening Ischemia in Patients with Peripheral Artery Disease. J Clin Med 2020; 9:jcm9061877. [PMID: 32560175 PMCID: PMC7355749 DOI: 10.3390/jcm9061877] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2020] [Revised: 05/30/2020] [Accepted: 06/10/2020] [Indexed: 12/11/2022] Open
Abstract
Peripheral artery disease (PAD) is characterized by the atherosclerotic narrowing of lower limb vessels, leading to ischemic muscle pain in older persons. Some patients experience progression to advanced chronic limb-threatening ischemia (CLTI) with poor long-term survivorship. Herein, we performed serum metabolomics to reveal the mechanisms of PAD pathophysiology that may improve its diagnosis and prognosis to CLTI complementary to the ankle-brachial index (ABI) and clinical presentations. Non-targeted metabolite profiling of serum was performed by multisegment injection-capillary electrophoresis-mass spectrometry (MSI-CE-MS) from age and sex-matched, non-diabetic, PAD participants who were recruited and clinically stratified based on the Rutherford classification into CLTI (n = 18) and intermittent claudication (IC, n = 20). Compared to the non-PAD controls (n = 20), PAD patients had lower serum concentrations of creatine, histidine, lysine, oxoproline, monomethylarginine, as well as higher circulating phenylacetylglutamine (p < 0.05). Importantly, CLTI cases exhibited higher serum concentrations of carnitine, creatinine, cystine and trimethylamine-N-oxide along with lower circulating fatty acids relative to well matched IC patients. Most serum metabolites associated with PAD progression were also correlated with ABI (r = ±0.24-0.59, p < 0.05), whereas the ratio of stearic acid to carnitine, and arginine to propionylcarnitine differentiated CLTI from IC with good accuracy (AUC = 0.87, p = 4.0 × 10-5). This work provides new biochemical insights into PAD progression for the early detection and surveillance of high-risk patients who may require peripheral vascular intervention to prevent amputation and premature death.
Collapse
|
6
|
Ismaeel A, Franco ME, Lavado R, Papoutsi E, Casale GP, Fuglestad M, Mietus CJ, Haynatzki GR, Smith RS, Bohannon WT, Sawicki I, Pipinos II, Koutakis P. Altered Metabolomic Profile in Patients with Peripheral Artery Disease. J Clin Med 2019; 8:E1463. [PMID: 31540015 PMCID: PMC6780416 DOI: 10.3390/jcm8091463] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2019] [Revised: 09/11/2019] [Accepted: 09/12/2019] [Indexed: 12/15/2022] Open
Abstract
Peripheral artery disease (PAD) is a common atherosclerotic disease characterized by narrowed or blocked arteries in the lower extremities. Circulating serum biomarkers can provide significant insight regarding the disease progression. Here, we explore the metabolomics signatures associated with different stages of PAD and investigate potential mechanisms of the disease. We compared the serum metabolites of a cohort of 26 PAD patients presenting with claudication and 26 PAD patients presenting with critical limb ischemia (CLI) to those of 26 non-PAD controls. A difference between the metabolite profiles of PAD patients from non-PAD controls was observed for several amino acids, acylcarnitines, ceramides, and cholesteryl esters. Furthermore, our data demonstrate that patients with CLI possess an altered metabolomic signature different from that of both claudicants and non-PAD controls. These findings provide new insight into the pathophysiology of PAD and may help develop future diagnostic procedures and therapies for PAD patients.
Collapse
Affiliation(s)
- Ahmed Ismaeel
- Department of Nutrition, Food and Exercise Sciences, Florida State University, Tallahassee, FL 32306, USA
| | - Marco E Franco
- Department of Environmental Science, Baylor University, Waco, TX 76798, USA
| | - Ramon Lavado
- Department of Environmental Science, Baylor University, Waco, TX 76798, USA
| | - Evlampia Papoutsi
- Department of Nutrition, Food and Exercise Sciences, Florida State University, Tallahassee, FL 32306, USA
| | - George P Casale
- Department of Surgery, University of Nebraska at Medical Center, Omaha, NE 68198, USA
| | - Matthew Fuglestad
- Department of Surgery, University of Nebraska at Medical Center, Omaha, NE 68198, USA
| | - Constance J Mietus
- Department of Surgery, University of Nebraska at Medical Center, Omaha, NE 68198, USA
| | - Gleb R Haynatzki
- Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE 68198, USA
| | - Robert S Smith
- Department of Surgery, Baylor Scott and White Hospital, Temple, TX 76508, USA
| | - William T Bohannon
- Department of Surgery, Baylor Scott and White Hospital, Temple, TX 76508, USA
| | - Ian Sawicki
- Department of Surgery, Baylor Scott and White Hospital, Temple, TX 76508, USA
| | - Iraklis I Pipinos
- Department of Surgery, University of Nebraska at Medical Center, Omaha, NE 68198, USA
| | - Panagiotis Koutakis
- Department of Nutrition, Food and Exercise Sciences, Florida State University, Tallahassee, FL 32306, USA.
| |
Collapse
|
7
|
Luck MM, Le Moyec L, Barrey E, Triba MN, Bouchemal N, Savarin P, Robert C. Energetics of endurance exercise in young horses determined by nuclear magnetic resonance metabolomics. Front Physiol 2015; 6:198. [PMID: 26347654 PMCID: PMC4544308 DOI: 10.3389/fphys.2015.00198] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2015] [Accepted: 06/29/2015] [Indexed: 01/12/2023] Open
Abstract
Long-term endurance exercise severely affects metabolism in both human and animal athletes resulting in serious risk of metabolic disorders during or after competition. Young horses (up to 6 years old) can compete in races up to 90 km despite limited scientific knowledge of energetic metabolism responses to long distance exercise in these animals. The hypothesis of this study was that there would be a strong effect of endurance exercise on the metabolomic profiles of young horses and that the energetic metabolism response in young horses would be different from that of more experienced horses. Metabolomic profiling is a powerful method that combines Nuclear Magnetic Resonance (NMR) spectrometry with supervised Orthogonal Projection on Latent Structure (OPLS) statistical analysis. 1H-NMR spectra were obtained from plasma samples drawn from young horses (before and after competition). The spectra obtained before and after the race from the same horse (92 samples) were compared using OPLS. The statistical parameters showed the robustness of the model (R2Y = 0.947, Q2Y = 0.856 and cros-validated ANOVA p < 0.001). For confirmation of the predictive value of the model, a test set of 104 sample spectra were projected by the model, which provided perfect predictions as the area under the receiving-operator curve was 1. The metabolomic profile determined with the OPLS model showed that glycemia after the race was lower than glycemia before the race, despite the involvement of lipid and protein catabolism. An OPLS model was calculated to compare spectra obtained on plasma taken after the race from 6-year-old horses and from experienced horses (cross-validated ANOVA p < 0.001). The comparison of metabolomic profiles in young horses to those from experienced horses showed that experienced horses maintained their glycemia with higher levels of lactate and a decrease of plasma lipids after the race.
Collapse
Affiliation(s)
- Margaux M Luck
- Unité de Biologie Intégrative et Adaptation à l'Exercice EA 7362, Université d'Evry Val D'Essonne Evry, France
| | - Laurence Le Moyec
- Unité de Biologie Intégrative et Adaptation à l'Exercice EA 7362, Université d'Evry Val D'Essonne Evry, France
| | - Eric Barrey
- Unité de Biologie Intégrative et Adaptation à l'Exercice EA 7362, Université d'Evry Val D'Essonne Evry, France ; Génétique Animale et Biologie Intégrative, UMR1313, Institut National de la Recherche Agronomique (INRA) Jouy-en-Josas, France
| | - Mohamed N Triba
- Chimie Structures et Propriétés de Biomatériaux et d'Agents Thérapeutiques (CSPBAT), Centre National de la Recherche Scientifique, Université Paris 13, Sorbonne Paris Cité, UMR 7244 Bobigny, France
| | - Nadia Bouchemal
- Chimie Structures et Propriétés de Biomatériaux et d'Agents Thérapeutiques (CSPBAT), Centre National de la Recherche Scientifique, Université Paris 13, Sorbonne Paris Cité, UMR 7244 Bobigny, France
| | - Philippe Savarin
- Chimie Structures et Propriétés de Biomatériaux et d'Agents Thérapeutiques (CSPBAT), Centre National de la Recherche Scientifique, Université Paris 13, Sorbonne Paris Cité, UMR 7244 Bobigny, France
| | - Céline Robert
- Génétique Animale et Biologie Intégrative, UMR1313, Institut National de la Recherche Agronomique (INRA) Jouy-en-Josas, France ; Ecole Nationale Vétérinaire d'Alfort, Université Paris Est Maisons-Alfort, France
| |
Collapse
|
8
|
Zagura M, Kals J, Kilk K, Serg M, Kampus P, Eha J, Soomets U, Zilmer M. Metabolomic signature of arterial stiffness in male patients with peripheral arterial disease. Hypertens Res 2015; 38:840-6. [PMID: 26134123 DOI: 10.1038/hr.2015.71] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2015] [Revised: 03/26/2015] [Accepted: 04/16/2015] [Indexed: 11/09/2022]
Abstract
Arterial stiffness is an independent determinant of cardiovascular risk and a marker of subclinical organ damage. Metabolomics may facilitate identification of novel low-molecular cardiovascular risk factors. The aim of the present study was to compare metabolic signatures and functional-biochemical characteristics of patients with peripheral arterial disease (PAD) and clinically healthy subjects. We studied 42 men with symptomatic PAD (aged 66±7 years) and 46 healthy men (aged 66±8 years). Aortic pulse wave velocity (aPWV) was assessed by applanation tonometry using the Sphygmocor device. Metabolic profiling was performed with high-performance liquid chromatography and mass spectrometry. Serum oxidized low-density lipoprotein (oxLDL) level was measured by enzyme-linked immunosorbent assay. The aPWV as well as serum levels of lactate, free carnitine and 11 amino acids including tyrosine were higher among the patients with PAD. In contrast, serum levels of pyruvate, citrate, α-ketoglutarate, aconitate and cysteine were higher in the control group. In multiple regression models, aPWV was independently determined by log-tyrosine and log-oxLDL in the patients (R(2)=0.61; P<0.001) and by age, log-pyruvate and log-oxLDL in the controls (R(2)=0.52; P<0.001). Our study describes for the first time significant differences in metabolomic signature of patients with advanced atherosclerosis compared with clinically healthy controls. The aPWV is independently associated with serum levels of tyrosine and oxLDL in the patients with PAD and is related to pyruvate and oxLDL levels in the control group. The measurement of low-molecular metabolites, which are related to changes in vascular phenotypes, may lead to identification of novel vascular risk markers.
Collapse
Affiliation(s)
- Maksim Zagura
- Department of Biochemistry, Institute of Biomedicine and Translational Medicine, Centre of Excellence for Translational Medicine, University of Tartu, Tartu, Estonia.,Endothelial Centre, University of Tartu, Tartu, Estonia.,Department of Cardiology, University of Tartu, Tartu, Estonia
| | - Jaak Kals
- Department of Biochemistry, Institute of Biomedicine and Translational Medicine, Centre of Excellence for Translational Medicine, University of Tartu, Tartu, Estonia.,Endothelial Centre, University of Tartu, Tartu, Estonia.,Department of Vascular Surgery, Tartu University Hospital, Tartu, Estonia
| | - Kalle Kilk
- Department of Biochemistry, Institute of Biomedicine and Translational Medicine, Centre of Excellence for Translational Medicine, University of Tartu, Tartu, Estonia
| | - Martin Serg
- Endothelial Centre, University of Tartu, Tartu, Estonia.,Department of Cardiology, University of Tartu, Tartu, Estonia
| | - Priit Kampus
- Endothelial Centre, University of Tartu, Tartu, Estonia.,Department of Cardiology, University of Tartu, Tartu, Estonia
| | - Jaan Eha
- Endothelial Centre, University of Tartu, Tartu, Estonia.,Department of Cardiology, University of Tartu, Tartu, Estonia
| | - Ursel Soomets
- Department of Biochemistry, Institute of Biomedicine and Translational Medicine, Centre of Excellence for Translational Medicine, University of Tartu, Tartu, Estonia
| | - Mihkel Zilmer
- Department of Biochemistry, Institute of Biomedicine and Translational Medicine, Centre of Excellence for Translational Medicine, University of Tartu, Tartu, Estonia.,Endothelial Centre, University of Tartu, Tartu, Estonia
| |
Collapse
|
9
|
de la Cuesta F, Mourino-Alvarez L, Baldan-Martin M, Moreno-Luna R, Barderas MG. Contribution of proteomics to the management of vascular disorders. TRANSLATIONAL PROTEOMICS 2015. [DOI: 10.1016/j.trprot.2014.10.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
|
10
|
Kordalewska M, Markuszewski MJ. Metabolomics in cardiovascular diseases. J Pharm Biomed Anal 2015; 113:121-36. [PMID: 25958299 DOI: 10.1016/j.jpba.2015.04.021] [Citation(s) in RCA: 62] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2015] [Revised: 04/16/2015] [Accepted: 04/18/2015] [Indexed: 12/17/2022]
Abstract
Cardiovascular diseases (CVDs) are the main cause of death globally. There is a need for the development of specific diagnostic methods, more effective therapeutic procedures as well as drugs, which can decrease the risk of deaths in the course of CVDs. For this reason, better understanding and explanation of molecular pathomechanisms of CVDs are essential. Metabolomics is focused on analysis of metabolites, small molecules which reflect the state of an organism in a certain point of time. Application of metabolomics approach in the investigation of molecular processes responsible for CVDs development may provide valuable information. In this article we overviewed recent reports employing application of untargeted and targeted metabolomic analyses in particular CVDs. Moreover, we focused on applications of various analytical platforms and metabolomics approaches which may contribute to the explanation of the pathomechanisms of different cardiovascular diseases.
Collapse
Affiliation(s)
- Marta Kordalewska
- Department of Biopharmaceutics and Pharmacodynamics, Medical University of Gdańsk, Al. Gen. J. Hallera 107, 80-416, Gdańsk, Poland
| | - Michał J Markuszewski
- Department of Biopharmaceutics and Pharmacodynamics, Medical University of Gdańsk, Al. Gen. J. Hallera 107, 80-416, Gdańsk, Poland.
| |
Collapse
|
11
|
Le Moyec L, Robert C, Triba MN, Billat VL, Mata X, Schibler L, Barrey E. Protein catabolism and high lipid metabolism associated with long-distance exercise are revealed by plasma NMR metabolomics in endurance horses. PLoS One 2014; 9:e90730. [PMID: 24658361 PMCID: PMC3962349 DOI: 10.1371/journal.pone.0090730] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2013] [Accepted: 02/03/2014] [Indexed: 12/26/2022] Open
Abstract
During long distance endurance races, horses undergo high physiological and metabolic stresses. The adaptation processes involve the modulation of the energetic pathways in order to meet the energy demand. The aims were to evaluate the effects of long endurance exercise on the plasma metabolomic profiles and to investigate the relationships with the individual horse performances. The metabolomic profiles of the horses were analyzed using the non-dedicated methodology, NMR spectroscopy and statistical multivariate analysis. The advantage of this method is to investigate several metabolomic pathways at the same time in a single sample. The plasmas were obtained before exercise (BE) and post exercise (PE) from 69 horses competing in three endurance races at national level (130-160 km). Biochemical assays were also performed on the samples taken at PE. The proton NMR spectra were compared using the supervised orthogonal projection on latent structure method according to several factors. Among these factors, the race location was not significant whereas the effect of the race exercise (sample BE vs PE of same horse) was highly discriminating. This result was confirmed by the projection of unpaired samples (only BE or PE sample of different horses). The metabolomic profiles proved that protein, energetic and lipid metabolisms as well as glycoproteins content are highly affected by the long endurance exercise. The BE samples from finisher horses could be discriminated according to the racing speed based on their metabolomic lipid content. The PE samples could be discriminated according to the horse ranking position at the end of the race with lactate as unique correlated metabolite. As a conclusion, the metabolomic profiles of plasmas taken before and after the race provided a better understanding of the high energy demand and protein catabolism pathway that could expose the horses to metabolic disorders.
Collapse
Affiliation(s)
- Laurence Le Moyec
- Unité de Biologie Intégrative et Adaptation à l'Exercice, Université d'Evry Val D'Essonne-Inserm, Evry, France
- * E-mail:
| | - Céline Robert
- Génétique Animale et Biologie Intégrative, INRA, Jouy-en-Josas, France
- Ecole Nationale Vétérinaire d'Alfort, Université Paris Est, Maisons-Alfort, France
| | - Mohamed N. Triba
- Chimie Structures Propriétés de Biomatériaux et d'Agents Thérapeutiques, Université Paris 13 Sorbonne Paris Cité-CNRS, Bobigny, France
| | - Véronique L. Billat
- Unité de Biologie Intégrative et Adaptation à l'Exercice, Université d'Evry Val D'Essonne-Inserm, Evry, France
| | - Xavier Mata
- Génétique Animale et Biologie Intégrative, INRA, Jouy-en-Josas, France
| | - Laurent Schibler
- Génétique Animale et Biologie Intégrative, INRA, Jouy-en-Josas, France
| | - Eric Barrey
- Unité de Biologie Intégrative et Adaptation à l'Exercice, Université d'Evry Val D'Essonne-Inserm, Evry, France
- Génétique Animale et Biologie Intégrative, INRA, Jouy-en-Josas, France
| |
Collapse
|